Celldex (CLDX) Tops Q2 EPS by 2c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.39 million versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Guggenheim flags this biotech stocks as one of its top picks
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings